Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & EquivalentsCommon EquityLiabilities and Shareholders EquityOther Non-Current LiabilitiesPayablesRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Greenwich LifeSciences (GLSI) Short term Debt (2019 - 2020)

Greenwich LifeSciences filings provide 2 years of Short term Debt readings, the most recent being $275154.0 for Q4 2020.

  • Quarterly Short term Debt fell 56.68% to $275154.0 in Q4 2020 from the year-ago period, while the trailing twelve-month figure was $275154.0 through Dec 2020, down 56.68% year-over-year, with the annual reading at $275154.0 for FY2020, 56.68% down from the prior year.
  • Short term Debt hit $275154.0 in Q4 2020 for Greenwich LifeSciences, down from $635154.0 in the prior quarter.
  • Across five years, Short term Debt topped out at $12.0 million in Q3 2019 and bottomed at $275154.0 in Q4 2020.